International Biotechnology Trust PLC Beam Therapeutics Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 23,500 shares of BEAM stock, worth $634,500. This represents 0.19% of its overall portfolio holdings.
Number of Shares
23,500
Previous 23,500
-0.0%
Holding current value
$634,500
Previous $750,000
24.67%
% of portfolio
0.19%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$270 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$262 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$239 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$206 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$128 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.9B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...